10208 Results

People

  1. Gonen
    Gonen
  2. Vickers
    Vickers
  3. Panageas
    Panageas
  4. Patil
    Patil
  5. Schultz
    Schultz
  6. Giralt
    Giralt
  7. Zhang
    Zhang
  8. Jarnagin
    Jarnagin
  9. Heller
    Heller
  10. D'Angelica
    D'Angelica

Groups

  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)
  7. Solid Tumor Oncology Division (3294)
  8. GSK Faculty (2808)
  9. Center for Pancreatic Cancer Research (2495)
  10. Health Outcomes Research Group (2069)
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6429)
  2. Meeting Abstract (3246)
  3. Editorial (116)
  4. Review (93)
  5. Research Letter (80)
  6. Correspondence (77)
  7. Conference Paper (54)
  8. Miscellaneous (52)
  9. Book Section (43)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)

More Groups

People
  1. Mithat Gonen (1028)
  2. Andrew Vickers (880)
  3. Sean Devlin (601)
  4. Katherine Panageas (512)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (486)

More People

Years
  1. 2025 (210)
  2. 2024 (622)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1374)
  2. Blood (534)
  3. Annals of Surgical Oncology (462)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (258)
  6. Clinical Cancer Research (250)

More Publications

Publishers
  1. American Society of Clinical Oncology (1487)
  2. Elsevier Inc. (1206)
  3. Springer (925)
  4. American Association for Cancer Research (761)
  5. Elsevier Science, Inc. (685)
  6. American Society of Hematology (601)

More Publishers

Results (10208)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of tyrosine kinase inhibitors in combination with various treatments regimens in adult patients with Philadelphia chromosome positive acute lymphocytic leukemia
    Meeting Abstract

    Lin, A.; Zhou, Q.; Devlin, S.; Adel, N. G.; Douer, D.
    Blood (2013)

    Fulltext@MSK | Save
  • Increased incidence of melanoma and non-melanoma skin cancers in patients with hairy cell leukemia: A single institution experience with 267 patients from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Watts, J. M.; Kishtagari, A.; Devlin, S.; Stein, E. M.; Park, J. H.; Lacouture, M. E.; Tallman, M.
    Blood (2013)

    Fulltext@MSK | Save
  • Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)
    Meeting Abstract

    Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin
    Meeting Abstract

    Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Integrated genetic profiling of JAK2 wildtype chronic-phase myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; Patel, J. P.; Knapp, K. M.; Patel, M.; Greenbowe, J. R.; Young, L. E.; He, J.; Wang, K.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk
    Meeting Abstract

    Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed multiple myeloma and high-risk cytogenetics permits long-lasting remissions in the absence of graft-versus-host disease
    Meeting Abstract

    Koehne, G.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S.
    Blood (2013)

    Fulltext@MSK | Save